Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Spire

Showing results (181-190 of 335) with videos related to

Pageof 34
Sort By:
Antiviral Therapy|August 5, 2008
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trialBruno Spire, Fabienne Marcellin, Isabelle Cohen-Codar, et al.
Antiviral Therapy|October 30, 2013
Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohortPerrine Roux, Caroline Lions, Julien Cohen, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Antiviral Therapy|May 11, 2011
Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV careSophie Rasson, Sylvie Boyer, Lionel Fugon, et al.
Plos One|February 18, 2021
Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM)Marion Fiorentino, Abdourahmane Sow, Luis Sagaon-Teyssier, et al.
AIDS (London, England)|April 3, 2009
Delayed first consultation after diagnosis of HIV infection in CameroonFabienne Marcellin, Claude Abé, Sandrine Loubière, et al.
AIDS Care|March 16, 2016
"We are our choices"--AIDS impact special issue Amsterdam 2015Udi Davidovich, Kai Jonas, Jose Catalan, et al.
The International Journal on Drug Policy|August 11, 2007
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)Maria Patrizia Carrieri, Virginie Villes, François Raffi, et al.
Substance Abuse Treatment, Prevention, and Policy|August 25, 2025
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction servicesLuis Sagaon-Teyssier, Maxime Hoyer, Cécile Donadille, et al.
AIDS (London, England)|September 15, 2004
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow upEmmanuelle Vincent, Anne-Déborah Bouhnik, Maria Patrizia Carrieri, et al.
Pageof 34

Showing results (181-190 of 335) with videos related to

Sort By:
Pageof 34
Antiviral Therapy|August 5, 2008
Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trialBruno Spire, Fabienne Marcellin, Isabelle Cohen-Codar, et al.
Antiviral Therapy|October 30, 2013
Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohortPerrine Roux, Caroline Lions, Julien Cohen, et al.
Antiviral Therapy|November 21, 2007
The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practiceVirginie Villes, Bruno Spire, Charlotte Lewden, et al.
Antiviral Therapy|May 11, 2011
Decentralization of access to antiretroviral therapy in Cameroon: correlates of HIV physicians' knowledge in HIV careSophie Rasson, Sylvie Boyer, Lionel Fugon, et al.
Plos One|February 18, 2021
Intimate partner violence by men living with HIV in Cameroon: Prevalence, associated factors and implications for HIV transmission risk (ANRS-12288 EVOLCAM)Marion Fiorentino, Abdourahmane Sow, Luis Sagaon-Teyssier, et al.
AIDS (London, England)|April 3, 2009
Delayed first consultation after diagnosis of HIV infection in CameroonFabienne Marcellin, Claude Abé, Sandrine Loubière, et al.
AIDS Care|March 16, 2016
"We are our choices"--AIDS impact special issue Amsterdam 2015Udi Davidovich, Kai Jonas, Jose Catalan, et al.
The International Journal on Drug Policy|August 11, 2007
Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8)Maria Patrizia Carrieri, Virginie Villes, François Raffi, et al.
Substance Abuse Treatment, Prevention, and Policy|August 25, 2025
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction servicesLuis Sagaon-Teyssier, Maxime Hoyer, Cécile Donadille, et al.
AIDS (London, England)|September 15, 2004
Impact of HAART-related side effects on unsafe sexual behaviours in HIV-infected injecting drug users: 7-year follow upEmmanuelle Vincent, Anne-Déborah Bouhnik, Maria Patrizia Carrieri, et al.
Pageof 34